Filing Details
- Accession Number:
- 0000950170-25-030330
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-03 06:01:08
- Reporting Period:
- 2025-02-27
- Filing Date:
- 2025-03-03
- Accepted Time:
- 2025-03-03 06:01:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
886744 | Geron Corp | GERN | Pharmaceutical Preparations (2834) | 752287752 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1987259 | Alan Scott Samuels | C/O Geron Corporation 919 E Hillsdale Blvd. Suite 250 Foster City CA 94404 | Evp, Chief Legal Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-02-27 | 15,000 | $1.61 | 26,682 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The reported transaction represents the open market purchase of 15,000 shares at an executed price of $1.61 per share.
- The number of securities reported reflects the open market purchase of 15,000 shares and acquisition on June 30, 2024 of 7,432 shares and on December 31, 2024 of 4,250 shares of Geron common stock pursuant to the Employee Stock.